News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
287,822 Results
Type
Article (15215)
Company Profile (298)
Press Release (272304)
Multimedia
Podcasts (97)
Webinars (12)
Section
Business (79958)
Career Advice (164)
Deals (13395)
Drug Delivery (44)
Drug Development (50825)
Employer Resources (31)
FDA (5902)
Job Trends (5188)
News (145391)
Policy (10081)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (938)
Accelerated approval (28)
Adcomms (14)
Allergies (102)
Alliances (21763)
ALS (162)
Alzheimer's disease (1131)
Antibody-drug conjugate (ADC) (380)
Approvals (6185)
Artificial intelligence (354)
Autoimmune disease (246)
Automation (11)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (121)
Biotechnology (228)
Bladder cancer (121)
Brain cancer (58)
Breast cancer (417)
Cancer (3932)
Cardiovascular disease (291)
Career advice (153)
Career pathing (10)
CAR-T (269)
CDC (8)
Celiac Disease (1)
Cell therapy (717)
Cervical cancer (22)
Clinical research (44810)
Collaboration (1432)
Company closure (3)
Compensation (738)
Complete response letters (55)
COVID-19 (1124)
CRISPR (106)
C-suite (760)
Cystic fibrosis (120)
Data (5661)
Denatured (20)
Depression (114)
Dermatology (55)
Diabetes (307)
Diagnostics (1442)
Digital health (17)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (259)
Drug pricing (52)
Drug shortages (3)
Duchenne muscular dystrophy (272)
Earnings (32756)
Editorial (33)
Employer branding (4)
Employer resources (29)
Events (53338)
Executive appointments (694)
FDA (8064)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (17)
Frontotemporal dementia (31)
Funding (1177)
Gene editing (225)
Generative AI (30)
Gene therapy (602)
GLP-1 (559)
Government (1183)
Grass and pollen (3)
Guidances (173)
Healthcare (6710)
HIV (27)
Huntington's disease (50)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (86)
Immunology and inflammation (235)
Immuno-oncology (79)
Indications (127)
Infectious disease (1274)
Inflammatory bowel disease (182)
Inflation Reduction Act (10)
Influenza (55)
Intellectual property (201)
Interviews (18)
IPO (7365)
IRA (13)
Job creations (869)
Job search strategy (131)
JPM (41)
Kidney cancer (9)
Labor market (30)
Layoffs (253)
Leadership (13)
Legal (1403)
Liver cancer (46)
Longevity (24)
Lung cancer (519)
Lymphoma (293)
Machine learning (33)
Management (7)
Manufacturing (513)
MASH (161)
Medical device (2700)
Medtech (2719)
Mergers & acquisitions (6754)
Metabolic disorders (886)
mRNA (158)
Multiple sclerosis (123)
NASH (14)
Neurodegenerative disease (317)
Neuropsychiatric disorders (82)
Neuroscience (2283)
Neurotech (1)
NextGen: Class of 2026 (2037)
Non-profit (876)
Now hiring (39)
Obesity (394)
Opinion (140)
Ovarian cancer (182)
Pain (133)
Pancreatic cancer (221)
Parkinson's disease (297)
Partnered (12)
Patents (385)
Patient recruitment (496)
Peanut (47)
People (27170)
Pharmaceutical (42)
Pharmacy benefit managers (6)
Phase 1 (15888)
Phase 2 (20862)
Phase 3 (13129)
Pipeline (5794)
Policy (104)
Postmarket research (853)
Preclinical (6749)
Press Release (30)
Prostate cancer (193)
Psychedelics (58)
Radiopharmaceuticals (278)
Rare diseases (855)
Real estate (1458)
Recruiting (12)
Regulatory (10518)
Reports (20)
Research institute (982)
Resumes & cover letters (20)
Rett syndrome (35)
RNA editing (27)
RSV (24)
Schizophrenia (146)
Series A (230)
Series B (159)
Service/supplier (1)
Sickle cell disease (90)
Special edition (20)
Spinal muscular atrophy (125)
Sponsored (17)
Startups (2028)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (19)
The Weekly (75)
Vaccines (391)
Venture capital (86)
Weight loss (211)
Women's health (45)
Worklife (2)
Date
Today (30)
Last 7 days (358)
Last 30 days (1968)
Last 365 days (17806)
2026 (7934)
2025 (18096)
2024 (20536)
2023 (22411)
2022 (26821)
2021 (27803)
2020 (23354)
2019 (16222)
2018 (11736)
2017 (13744)
2016 (11838)
2015 (14348)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (154)
Alabama (72)
Alaska (2)
Arizona (82)
Arkansas (6)
Asia (18630)
Australia (3193)
California (8477)
Canada (2167)
China (984)
Colorado (303)
Connecticut (316)
Delaware (288)
Europe (40081)
Florida (1090)
Georgia (249)
Hawaii (2)
Idaho (18)
Illinois (499)
India (46)
Indiana (196)
Iowa (8)
Japan (294)
Kansas (83)
Kentucky (11)
Louisiana (14)
Maine (12)
Maryland (873)
Massachusetts (6726)
Michigan (127)
Minnesota (303)
Mississippi (3)
Missouri (35)
Montana (17)
Nebraska (6)
Nevada (47)
New Hampshire (22)
New Jersey (1928)
New Mexico (13)
New York (2107)
North Carolina (994)
North Dakota (7)
Northern California (4291)
Ohio (212)
Oklahoma (11)
Oregon (23)
Pennsylvania (1563)
Puerto Rico (11)
Rhode Island (27)
South America (216)
South Carolina (12)
Southern California (3393)
Tennessee (50)
Texas (1152)
United States (28008)
Utah (118)
Virginia (172)
Washington D.C. (37)
Washington State (695)
West Virginia (1)
Wisconsin (57)
287,822 Results for "lisata therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
March 9, 2026
·
9 min read
Press Releases
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
January 28, 2026
·
6 min read
Press Releases
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
January 21, 2026
·
8 min read
Press Releases
Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for ‘Overall BioPharma Solution of the Year’
November 7, 2025
·
10 min read
Press Releases
Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 6, 2025
·
16 min read
Press Releases
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
October 9, 2025
·
8 min read
Press Releases
Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
October 31, 2025
·
1 min read
Press Releases
Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial
September 30, 2025
·
9 min read
Press Releases
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent
November 4, 2025
·
7 min read
Press Releases
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025
·
1 min read
1 of 28,783
Next
